相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Liquid Biopsy in Breast Cancer
Timothy Kwang Yong Tay et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction
Shiyu Li et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
Amir Sadra Zangouei et al.
CANCER CELL INTERNATIONAL (2021)
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
Ghazaleh Khalili-Tanha et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2021)
Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
Wenxin Zeng et al.
CANCER CELL INTERNATIONAL (2020)
Long non-coding RNAs as the critical factors during tumor progressions among Iranian population: an overview
Zahra Rahmani et al.
CELL AND BIOSCIENCE (2020)
p27 as a Transcriptional Regulator: New Roles in Development and Cancer
Seyedeh Fatemeh Razavipour et al.
CANCER RESEARCH (2020)
Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/CDK2 axis promotes progression of ER plus breast cancer and confers tamoxifen resistance
Jing Feng et al.
AGING-US (2020)
ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway
Zihui Fang et al.
CANCER RESEARCH (2020)
A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation
Yue Cui et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Long Noncoding RNA FOXC2-AS1 Predicts Poor Survival in Breast Cancer Patients and Promotes Cell Proliferation
Haisong Yang et al.
ONCOLOGY RESEARCH (2019)
LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer
Yun Ma et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Liquid biopsy in breast cancer: A comprehensive review
Sahar Alimirzaie et al.
CLINICAL GENETICS (2019)
Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors
Christopher Fitzpatrick et al.
CELL DEATH & DISEASE (2019)
KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation
Xiaoting Jia et al.
CELL DEATH & DISEASE (2019)
Chemoresistance mechanisms of breast cancer and their countermeasures
Xiwei Ji et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer
Hongfan Yuan et al.
ONCOTARGETS AND THERAPY (2019)
LncRNA LINC00668 promotes the progression of breast cancer by inhibiting apoptosis and accelerating cell cycle
Xia Qiu et al.
ONCOTARGETS AND THERAPY (2019)
LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
Bolun Ai et al.
CELL DEATH & DISEASE (2019)
Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model
Chang Yang et al.
CANCER CELL INTERNATIONAL (2019)
LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215
Xiaoli Kong et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment
Natalja Eigeliene et al.
ONCOLOGY (2019)
Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer
Shipeng Guo et al.
FRONTIERS IN ONCOLOGY (2019)
Activation of FOXO3a reverses 5-Fluorouracil resistance in human breast cancer cells
Ying Song et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line
Firooz J. Alipoor et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
Mohammad Reza Abbaszadegan et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)
High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway
Liguo Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma
Roland Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LncRNA MIR100HG promotes cell proliferation in triple- negative breast cancer through triplex formation with p27 loci
Shaowei Wang et al.
CELL DEATH & DISEASE (2018)
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Raffaele Palmirotta et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Long noncoding RNA linc-ITGB1 promotes cell migration and invasion in human breast cancer
Meidi Yan et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2017)
Regulation of E2F1 Transcription Factor by Ubiquitin Conjugation
Laurence Dubrez
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The HSP90 chaperone machinery
Florian H. Schopf et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator
Yin Zhang et al.
ONCOLOGY REPORTS (2017)
Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways
Sheng Chen et al.
ONCOLOGY LETTERS (2017)
Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model
Vincenzo Borgna et al.
ONCOTARGET (2017)
E2F1, a Novel Regulator of Metabolism
Pierre-Damien Denechaud et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
CANCER SCREENING AND EARLY DETECTION IN THE 21ST CENTURY
Jennifer T. Loud et al.
SEMINARS IN ONCOLOGY NURSING (2017)
Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer
Shulin Fan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Breast Cancer: Multiple Subtypes within a Tumor?
Syn Kok Yeo et al.
TRENDS IN CANCER (2017)
Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer
Xin Deng et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis
Zhengyu Jiang et al.
BREAST CANCER RESEARCH (2017)
PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6
Chen Yan et al.
CANCER SCIENCE (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation
A-S Tigan et al.
ONCOGENE (2016)
Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression
E Faghihloo et al.
CANCER GENE THERAPY (2016)
Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics
Ting Shi et al.
DISEASE MARKERS (2016)
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage
Ansar Karimian et al.
DNA REPAIR (2016)
Circulating tumor cell technologies
Meghaan M. Ferreira et al.
MOLECULAR ONCOLOGY (2016)
Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop
Xiunan Li et al.
TUMOR BIOLOGY (2016)
The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer
Francesco Crea et al.
EPIGENOMICS (2016)
miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation
Tongbao Feng et al.
ONCOTARGET (2016)
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
Vassiliki Saloura et al.
ONCOTARGET (2016)
Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors
Lorena Lobos-Gonzalez et al.
ONCOTARGET (2016)
LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16INK4A expression
Yi Sang et al.
SCIENTIFIC REPORTS (2016)
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
Muhammed Murtaza et al.
NATURE COMMUNICATIONS (2015)
Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology
Ilaria Dutto et al.
ARCHIVES OF TOXICOLOGY (2015)
The fate of chemoresistance in triple negative breast cancer (TNBC)
Elma A. O'Reilly et al.
BBA CLINICAL (2015)
Gastric Juice Long Noncoding RNA Used as a Tumor Marker for Screening Gastric Cancer
Yongfu Shao et al.
CANCER (2014)
Long Noncoding RNAs in Patients With Acute Myocardial Infarction
Melanie Vausort et al.
CIRCULATION RESEARCH (2014)
Biomarkers in prostate cancer: what's new?
David A. Sartori et al.
CURRENT OPINION IN ONCOLOGY (2014)
Down-regulation of the Antisense Mitochondrial Non-coding RNAs (ncRNAs) Is a Unique Vulnerability of Cancer Cells and a Potential Target for Cancer Therapy
Soledad Vidaurre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Molecular Balancing Act of p16INK4a in Cancer and Aging
Kyle M. LaPak et al.
MOLECULAR CANCER RESEARCH (2014)
lincRNAs: Genomics, Evolution, and Mechanisms
Igor Ulitsky et al.
CELL (2013)
The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness
Diego Sisci et al.
CELL CYCLE (2013)
Treatment of Estrogen Receptor-Positive Breast Cancer
F. Lumachi et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies
Johnny C. Akers et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis
Haikuo Tang et al.
MOLECULAR MEDICINE REPORTS (2013)
Expression of Mitochondrial Non-coding RNAs (ncRNAs) Is Modulated by High Risk Human Papillomavirus (HPV) Oncogenes
Claudio Villota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
Hifzur Rahman Siddique et al.
STEM CELLS (2012)
Perspectives of Long Non-Coding RNAs in Cancer Diagnostics
Eduardo M. Reis et al.
Frontiers in Genetics (2012)
In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
Florian A. Karreth et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
C. Romagosa et al.
ONCOGENE (2011)
Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance
Paromita Raha et al.
EPIGENOMICS (2011)
Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells
Marjorie E. Montanez-Wiscovich et al.
JOURNAL OF PATHOLOGY (2010)
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Ornella Cazzalini et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2010)
Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer
C. Elizabeth Caldon et al.
CELL DIVISION (2010)
CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical Relevance
Michaela J. Higgins et al.
CURRENT ONCOLOGY REPORTS (2010)
Development of Cell Cycle Inhibitors for Cancer Therapy
Gary K. Schwartz et al.
Current Oncology (2009)
Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model
Animesh Dhar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells
Veronica A. Burzio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
Ilija Androic et al.
BMC CANCER (2008)
Rational Management of Endocrine Resistance in Breast Cancer A Comprehensive Review of Estrogen Receptor Biology, Treatment Options, and Future Directions
Sara A. Hurvitz et al.
CANCER (2008)
CDC6:: from DNA replication to cell cycle checkpoints and oncogenesis
Luis R. Borlado et al.
CARCINOGENESIS (2008)
Expression of a novel non-coding mitochondrial RNA in human proliferating cells
Jaime Villegas et al.
NUCLEIC ACIDS RESEARCH (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P. Alao
MOLECULAR CANCER (2007)
Estrogen signaling multiple pathways to impact gene transcription
Maria Marino et al.
CURRENT GENOMICS (2006)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
Biomarkers and multiple drug resistance in breast cancer
L. O'Driscoll et al.
CURRENT CANCER DRUG TARGETS (2006)
Phosphatidylinositol 3′-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN
Wolfgang Hartmann et al.
CLINICAL CANCER RESEARCH (2006)
Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction
Nobuaki Ishii et al.
JOURNAL OF HUMAN GENETICS (2006)
H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1
N Berteaux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
JP Yuan et al.
ONCOGENE (2004)
Minireview: Cyclin D1: Normal and abnormal functions
MF Fu et al.
ENDOCRINOLOGY (2004)
Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C
SV Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
STAT proteins:: From normal control of cellular events to tumorigenesis
V Calò et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer
N Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
CK Osborne et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Jiyong Liang et al.
CELL CYCLE (2003)
Circulating DNA: a new diagnostic gold mine?
A Ziegler et al.
CANCER TREATMENT REVIEWS (2002)
The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer
JE Visvader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
D Kim et al.
FASEB JOURNAL (2001)
β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)